Celaid Therapeutics has been selected by JETRO to participate in the Startup City Acceleration Program (SCAP), a support program for Japanese startups expanding overseas.
In this program, world-class accelerators affiliated with JETRO will provide specialized courses by leveraging their strengths and provide individual support for Japanese startups to expand business overseas while closely working with them.